Fresenius Medical Care AG & Co KGaA ADR Stock
Fresenius Medical Care AG & Co KGaA ADR gained 0.520% compared to yesterday.
Pros and Cons of Fresenius Medical Care AG & Co KGaA ADR in the next few years
Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius Medical Care AG & Co KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | 0.520% | -1.015% | -5.340% | -12.946% | -11.364% | 32.653% | -42.647% |
| Carl Zeiss Meditec AG | 0.350% | -6.734% | -7.755% | -22.006% | -11.857% | -68.529% | -62.762% |
| Fresenius SE & Co. KGaA | -0.980% | 0.042% | -4.362% | 36.842% | 42.115% | 82.649% | 26.914% |
| Fresenius SE & Co. KGaA ADR | 2.630% | 0.862% | 0.000% | 37.647% | 42.683% | 84.252% | 25.134% |
Comments
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at UBS Group AG from a "sell" rating to an "underperform" rating.
Show more
Ratings data for FMS provided by MarketBeat
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by analysts at Bank of America Corporation from a "neutral" rating to an "underperform" rating.
Show more
Ratings data for FMS provided by MarketBeat